RT @theNCI: Pembrolizumab (Keytruda) shows promise vs melanoma-resistant ipilimumab (Yervoy): http://t.co/wAZoWH0TrO http://t.co/sHoaYukaYr

2:25pm July 21st 2015 via Hootsuite in reply to theNCI